PT Semen Indonesia (Persero) Tbk
PT Semen Indonesia (Persero) Tbk (PSGTF) Financial Performance & Income Statement Overview
Review PT Semen Indonesia (Persero) Tbk (PSGTF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
PT Semen Indonesia (Persero) Tbk (PSGTF) Income Statement & Financial Overview
Explore comprehensive income reports for PT Semen Indonesia (Persero) Tbk PSGTF, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $7654.75B | $9891.25B | $9883.56B | $8036.26B |
| Cost of Revenue | $6093.39B | $7976.79B | $7724.85B | $6550.23B |
| Gross Profit | $1561.36B | $1914.45B | $2158.71B | $1486.03B |
| Gross Profit Ratio | $0.20 | $0.19 | $0.22 | $0.18 |
| R&D Expenses | $3.41B | $17.50B | $9.80B | $3.02B |
| SG&A Expenses | $560.20B | $436.35B | $737.44B | $578.77B |
| Operating Expenses | $1306.58B | $1603.92B | $2158.71B | $1145.36B |
| Total Costs & Expenses | $7399.97B | $9580.71B | $9249.13B | $7695.59B |
| Interest Income | $39.21B | $98.09B | $19.30B | $65.25B |
| Interest Expense | $218.004B | $260.75B | $276.11B | $326.70B |
| Depreciation & Amortization | $157.52B | $157.43B | $154.61B | $825.31B |
| EBITDA | $467.33B | $595.52B | $788.98B | $1215.15B |
| EBITDA Ratio | $0.06 | $0.06 | $0.08 | $0.15 |
| Operating Income | $254.78B | $310.54B | $634.43B | $340.67B |
| Operating Income Ratio | $0.03 | $0.03 | $0.06 | $0.04 |
| Other Income/Expenses (Net) | -$153.21B | -$124.65B | -$282.67B | -$277.53B |
| Income Before Tax | $101.57B | $185.88B | $351.77B | $63.14B |
| Income Before Tax Ratio | $0.01 | $0.02 | $0.04 | $0.008 |
| Income Tax Expense | $66.14B | $155.66B | $113.81B | $30.48B |
| Net Income | $42.58B | $40.00M | $218.25B | $29.67B |
| Net Income Ratio | $0.006 | $0.00 | $0.02 | $0.004 |
| EPS | $6.00 | $0.006 | $32.33 | $4.39 |
| Diluted EPS | $6.00 | $0.006 | $32.33 | $4.39 |
| Weighted Avg Shares Outstanding | $6.75B | $6.75B | $6.75B | $6.75B |
| Weighted Avg Shares Outstanding (Diluted) | $6.75B | $6.75B | $6.75B | $6.75B |
Financial performance has remained strong, with revenue growing from $8036.26B in Q2 2024 to $7654.75B in Q1 2025. Gross profit continued to perform well, with margins at 20% in the latest quarter. Operating income reached $254.78B in Q1 2025, holding a steady 3% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $467.33B. Net income rose to $42.58B, keeping EPS at $6.00. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan